Australia markets open in 2 minutes

IDEX Biometrics ASA (IDBA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
21.30-0.68 (-3.08%)
At close: 9:30AM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5251.13M
Enterprise value 3232.51M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)105.85
Price/book (mrq)9.80
Enterprise value/revenue 3107.30
Enterprise value/EBITDA 7-8.77

Trading information

Stock price history

Beta (5Y monthly) 2.58
52-week change 3-24.46%
S&P500 52-week change 331.55%
52-week high 332.82
52-week low 316.14
50-day moving average 321.08
200-day moving average 320.72

Share statistics

Avg vol (3-month) 3346
Avg vol (10-day) 3671
Shares outstanding 512.26M
Implied shares outstanding 6N/A
Float 88.17M
% held by insiders 10.00%
% held by institutions 10.01%
Shares short (29 Sept 2021) 42.22k
Short ratio (29 Sept 2021) 47.01
Short % of float (29 Sept 2021) 4N/A
Short % of shares outstanding (29 Sept 2021) 40.02%
Shares short (prior month 30 Aug 2021) 4351

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 June 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,333.83%

Management effectiveness

Return on assets (ttm)-75.21%
Return on equity (ttm)-143.21%

Income statement

Revenue (ttm)2.17M
Revenue per share (ttm)0.22
Quarterly revenue growth (yoy)367.80%
Gross profit (ttm)820k
EBITDA -27.96M
Net income avi to common (ttm)-28.8M
Diluted EPS (ttm)-2.55
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)19.25M
Total cash per share (mrq)1.57
Total debt (mrq)636k
Total debt/equity (mrq)2.54
Current ratio (mrq)7.27
Book value per share (mrq)2.03

Cash flow statement

Operating cash flow (ttm)-25.98M
Levered free cash flow (ttm)-15.55M